A phase 1 study of AMG 757, half-life extended bispecific T-cell engager (BiTE®) immune therapy against DLL3, in SCLC Meeting Abstract
| Authors: | Owonikoko, T.; Boyer, M.; Johnson, M.; Govindan, R.; Rodrigues, L.; Blackhall, F.; Boosman, R.; Champiat, S.; Hummel, H.; Lai, W. V.; Udagawa, H.; Chiang, A.; Dowlati, A.; Hann, C.; Salgia, R.; Vokes, E.; Minocha, M.; Sadraei, N.; Shetty, A.; Smit, M.; Zhang, Y.; Sable, B.; Pati, A.; Roy, S.; Borghaei, H. |
| Abstract Title: | A phase 1 study of AMG 757, half-life extended bispecific T-cell engager (BiTE®) immune therapy against DLL3, in SCLC |
| Meeting Title: | 2020 World Conference on Lung Cancer |
| Keywords: | small cell lung cancer; atypical carcinoid; neuroendocrine tumours |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 28-31 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-03-01 |
| Start Page: | S126 |
| Language: | English |
| ACCESSION: | WOS:000631349600113 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2021.01.313 |
| Notes: | Meeting Abstract: OA11.03 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos |
